Matches in Wikidata for { <http://www.wikidata.org/entity/Q66029804> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- Q66029804 description "clinical trial" @default.
- Q66029804 description "ensayu clínicu" @default.
- Q66029804 description "klinisch onderzoek" @default.
- Q66029804 description "клінічне випробування" @default.
- Q66029804 name "Carotid B-mode Ultrasound Study to Compare Anti-Atherosclerotic Effect of Torcetrapib/Atorvastatin to Atorvastatin." @default.
- Q66029804 name "Carotid B-mode Ultrasound Study to Compare Anti-Atherosclerotic Effect of Torcetrapib/Atorvastatin to Atorvastatin." @default.
- Q66029804 type Item @default.
- Q66029804 label "Carotid B-mode Ultrasound Study to Compare Anti-Atherosclerotic Effect of Torcetrapib/Atorvastatin to Atorvastatin." @default.
- Q66029804 label "Carotid B-mode Ultrasound Study to Compare Anti-Atherosclerotic Effect of Torcetrapib/Atorvastatin to Atorvastatin." @default.
- Q66029804 prefLabel "Carotid B-mode Ultrasound Study to Compare Anti-Atherosclerotic Effect of Torcetrapib/Atorvastatin to Atorvastatin." @default.
- Q66029804 prefLabel "Carotid B-mode Ultrasound Study to Compare Anti-Atherosclerotic Effect of Torcetrapib/Atorvastatin to Atorvastatin." @default.
- Q66029804 P1050 Q66029804-B61EC46C-F30B-41D8-8860-A257D01AB972 @default.
- Q66029804 P1132 Q66029804-F6E65D5C-1406-4814-90E1-98568E726999 @default.
- Q66029804 P1476 Q66029804-55075290-0437-4613-8C3A-E9E45FCDC000 @default.
- Q66029804 P17 Q66029804-2703154E-78D5-4A25-8E8E-9400CE65F90F @default.
- Q66029804 P17 Q66029804-4C403D07-8E0B-45C2-9832-A65AE662D9AC @default.
- Q66029804 P17 Q66029804-698C6892-E9A6-4541-922D-DBEB9034869B @default.
- Q66029804 P17 Q66029804-905C02B7-156F-41B8-98D4-88995A1D6460 @default.
- Q66029804 P17 Q66029804-DA33CAE1-DFC6-4070-AEC2-F43DC41D5F40 @default.
- Q66029804 P17 Q66029804-F0C11DDE-BB40-4E19-9AF6-7C0C9009EF33 @default.
- Q66029804 P1813 Q66029804-DA32035D-D991-4E79-B73C-B79CFE0D62BD @default.
- Q66029804 P2899 Q66029804-59FDAEA2-3EBF-4032-B464-8FB0F9702ADF @default.
- Q66029804 P3098 Q66029804-00DA3914-1CF9-4C74-AB2A-FF4271B19E74 @default.
- Q66029804 P31 Q66029804-6D59CC00-8630-40D1-9130-73DCC57A701A @default.
- Q66029804 P4135 Q66029804-871F600E-5AFF-4409-AEDB-703D81212514 @default.
- Q66029804 P580 Q66029804-47598894-163E-4555-98C5-5C8DB82492BC @default.
- Q66029804 P582 Q66029804-684ADA36-91E4-441A-8A71-C53CC66847D0 @default.
- Q66029804 P6099 Q66029804-EF8301CE-F772-43F8-87F3-4BE5F8D29AA7 @default.
- Q66029804 P6153 Q66029804-16AD0F82-80AE-4C99-BCB3-FE1C86A283DD @default.
- Q66029804 P8363 Q66029804-C6F593B5-A5E2-4353-9907-59EB13F0BC3E @default.
- Q66029804 P1050 Q18554151 @default.
- Q66029804 P1132 "+755" @default.
- Q66029804 P1476 "Phase 3 Multi-Center, Double-Blind, Randomized, Parallel Group, Carotid B-mode Ultrasound Evaluation of the Anti-Atherosclerotic Efficacy, Safety, and Tolerability of Fixed Combination CP-529,414/Atorvastatin, Administered Orally, Once Daily (QD) for 24 Months, Compared With Atorvastatin Alone, in Subjects With Mixed Hyperlipidemia" @default.
- Q66029804 P17 Q142 @default.
- Q66029804 P17 Q16 @default.
- Q66029804 P17 Q213 @default.
- Q66029804 P17 Q30 @default.
- Q66029804 P17 Q33 @default.
- Q66029804 P17 Q55 @default.
- Q66029804 P1813 "RADIANCE 2" @default.
- Q66029804 P2899 "+18" @default.
- Q66029804 P3098 "NCT00134238" @default.
- Q66029804 P31 Q30612 @default.
- Q66029804 P4135 "+70" @default.
- Q66029804 P580 "2003-11-01T00:00:00Z" @default.
- Q66029804 P582 "2006-12-01T00:00:00Z" @default.
- Q66029804 P6099 Q42824827 @default.
- Q66029804 P6153 Q206921 @default.
- Q66029804 P8363 Q78089383 @default.